retatrutide diabetes type 1 How Does Work? Triple Agonist Explained Retatrutide as a Novel Treatment

With Eriomin, studies show it can take up to 12 weeks to see a significant boost in GLP-1

Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation

Ozempic Face is not a medical diagnosis

Tirzepatides influence on heart rate may be linked to its action on GLP-1 receptors, which are present in the heart and blood vessels

If no change, consider increasing to 0.1 mg weekly

This distinction matters because getting coverage often requires a diabetes diagnosis